20/20 BIOLABS, INC. Net Fee Amt
20/20 BIOLABS, INC. (AIDX) had Net Fee Amt of $2.53 thousand as of 2026-04-03, per its S-1 filed 2026-04-06.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-04-06
- 2026-04-03: Net Fee Amt $2.53K.
| Period end | Net Fee Amt |
|---|---|
| 2026-04-03 | $2.53K S-1 · filed 2026-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGENOMICS INC (NEO) | United States | $2.514B | -35.96 |